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Abstract 
Background: To determine the relationship between 
serum leptin and insulin resistance in obese Pakistani 
subjects. 
Methods: In this observational study fifty healthy 
obese and overweight subjects were selected by non-
probability convenience sampling. Age, sex, height, 
weight and body mass index (BMI) of subjects  were 
recorded. Fasting plasma glucose, serum leptin and 
insulin were measured. Fifty healthy non-obese subjects 
served as control group. 
Results: Serum leptin concentration was higher in 
obese subjects (52.8 ± 24.6 ng/ml), with p value 0.001 than 
in non-obese healthy controls (6.3 ± 3.1 ng/ml). Serum 
leptin level was found higher in women (64.4ng/ml) than 
in men (40.4ng/ml) only in obese group. Insulin resistance 
was higher in obese subjects (11.1 ± 5.1), with p value 0.001 
than control group (0.9 ± 0.4). BMI strongly correlated with 
leptin concentration (r = 0.59 & p = 0.001) and insulin 
resistance (r = 0.372 & p = 0.001) in obese group. There was 
highly significant correlation between serum leptin 
concentration and insulin resistance (r = 0.451 & p = 0.001) 
in this group. In the control group, there was no 
correlation between serum leptin concentration and 
insulin resistance (r = 0.166 & p = 0.249). 
Conclusions: Serum leptin is positively correlated 
with insulin resistance in obese subjects. Serum leptin 
level and insulin resistance are higher in obese subjects.  
 
Key Words: Leptin, insulin resistance, body mass 
index, obesity. 
 
Introduction 
Obesity is one of the major problems which the 
developed countries are facing and now it has become 
an increasing threat for developing countries also. The 
affluent class of these countries is facing the same 
problem. It is well known that obesity is a risk factor 
for the development of insulin resistance. Insulin 
resistance is the condition in which normal amounts of 
insulin are inadequate to produce proportionate 
insulin response in fat, muscle and liver cells.1,2 
     Leptin is a protein product of the obesity gene and 
involved in the regulation of energy intake and energy 
expenditure. Although few persons with extreme 
obesity are leptin deficient but most obese persons 
have hyper-leptinemia proportional to body fat and 
appear to be insulin resistant. The type of relationship 
between serum leptin and insulin resistance is not 
clear especially in obese subjects. Some studies have 
shown that insulin resistance is related with low levels 
of leptin in blood while other studies do not support 
it.3 The triad of obesity,insulin resistance and leptin 
still needs exploration in our setup. The present study 
was aimed to address this issue. 
 
Patients and Methods 
This observational study was conducted at Armed 
Forces Institute of Pathology & Benazir Bhutto 
Shaheed Hospital, Rawalpindi, Pakistan, from 
1.12.2008 to 30.5.2009.Fifty obese and overweight 
subjects were selected. Their age, height, weight and 
body mass index (BMI) were recorded. Serum leptin 
and insulin levels were measured in the fasting blood 
samples. Fifty healthy non-obese subjects were 
selected as control group. Weight of 23.1-27.4  
kg/m2,27.5-40  kg/m2 and  18.5-23.0 kg/m2 were 
considered as overweight, obese and non-obese, 
respectively. These BMI values were used under the 
“guidelines for Asian populations” issued in year 2000 
by The International Association for the Study of 
Obesity and the International Obesity Task Force of 
World Health Organization, Western Pacific Region, 
Australia.4 Height (cms) was measured using wall-
mounted stadiometer and weight (kg) was determined 
using a weighing balance to calculate BMI (as an 
expression of obesity). BMI was calculated by the 
formula: BMI= Weight (kg)/ Height (m2) 
      After an overnight fast, blood samples were 
obtained  in the morning between 0800-0900 hours for 
plasma glucose, insulin and leptin levels.Insulin 
resistance was calculated by Homeostasis Model 
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Assessment for Insulin Resistance (HOMA-IR) 
equation. 4,5  
HOMA-IR = Plasma glucose fasting (mmol/L) x 
Plasma insulin fasting (m IU/L)  22.5 
A value > 2.5 was considered as evidence of insulin 
resistance. 
   HOMA-β: Homeostasis Model Assessment for beta 
cell function (HOMA-β) was calculated by following 
formula: 
HOMA-β = 20 x insulin / glucose - 3.5 = % 
     Since Insulin sensitivity and β-cell function are 
inextricably linked they were measured 
simultaneously because their interplay is fundamental 
to glucose tolerance .6 For correlation between serum 
leptin and insulin resistance in healthy obese and non-
obese subjects r-values were determined by Pearson’s 
correlation test.  
 
Results 
    Serum leptin concentration was high in obese 
subjects (mean 52.8 ± 24.6 ng/ml), than in non-obese 
healthy controls (6.3 ± 3.1 ng/ml)(Table-1). Serum 
leptin level was found higher in women (64.4ng/ml) 
than in men (40.4ng/ml) in obese group (Table-2). In 
non obese control group this gender difference was 
less marked 8.0 ng/ml in women and 5.4 ng/ml in 
men. Insulin resistance was higher in obese subjects 
(11.1 ± 5.1), than control group (0.9 ± 0.4). Beta cell 
function was determined by HOMA-β. Mean Beta cell 
function in obese group was found to be lower 61.6 ± 
32.5% (range 29.1-94.1%) and in non-obese group it 
was higher 120 ± 94.6 % (range 25.4-214.6%)(Table-3). 
There was a significant difference between the two 
groups (p= 0.002). 
     BMI strongly positively correlated with leptin 
concentration (r = 0.59 & p = 0.001) (Fig 1) and insulin 
resistance (r = 0.372 & p = 0.001) in obese group. There 
was highly significant positive correlation between 
serum leptin concentration and insulin resistance (r = 
0.451 & p = 0.001) in obese group. However, in the 
control group, there was no correlation between 
serum leptin concentration and insulin resistance (r = 
0.166 & p = 0.249). 
 
Discussion 
     In the present study, a strong relationship between 
obesity and serum leptin was found in obese group. 
This was in agreement with previous studies.7-11  In the 
present study, serum leptin levels were measured in 
apparently healthy obese and healthy non obese 
adults. The present study showed that obesity, 
expressed by BMI, had a strong relation with insulin 
resistance (r=0.37, p value =0.001), which is in 
accordance with studies conducted by Barzilai et al, 
Jiali et al. & Reaven. 12-15 Insulin resistance was 
calculated using HOMA-IR equation, commonly 
employed  for population based studies because of its 
easy manageability.   
Table 1: Baseline characteristics of obese 
and non-obese subjects 
 
Parameters 
Obese (n═40) 
 
Mean  SD 
Non Obese/ 
Controls 
(n=50)  
Mean        SD  
 
P-
values 
Age (years) 34.8  4.6 32.7  6.1 0.948 
Height (cms) 163 6.7 167 6.7 0.004 
Weight (kg) 80 9.7 59 6.6 0.001 
BMI (kg/m2) 31.6  3.1 21.2  1.5 0.001 
FP Glucose (mmol/l) 5.8 1.1 4.9 0.9 0.001 
FP Insulin (IU/ml) 15.1 7.1 3.4 1.7 0.001 
Insulin resistance 
(HOMA-IR) 
11.1  5.1 0.9  0.4 0.001 
Beta cell function 
(HOMA-β = %) 
61.6 32.5 120 94.6 0.002 
S leptin (ng/ml) 52.8 24.6 6.3  3.1 0.001 
 
 
Table 2: Mean serum leptin levels with 
reference to BMI 
 BMI (kg/m2) 
Mean Serum 
Leptin (ng/ml)
Non obese 
18.5-23.0 
Overweight 
23.1-27.4 
Obese 
27.5-40.0 
Male 5.5 32.6 40.4 
Female 8.7 37.8 64.4 
 
Table 3: Comparison of BMI, serum leptin, 
insulin resistance & Beta cell function in 
obese & non-obese Subjects 
Parameters Obese  
 ( n=40) 
Mean ± SD  
Non obese 
(n=50) 
Mean ± SD  
P value 
BMI (kg/m2) 31.6 ± 3.1 21.2 ± 1.5 0.001 
Insulin 
Resistance 
11.1 ± 5.1 0.9 ± 0.4 0.001 
Beta cell 
function (%) 
61.6 ± 32.5 120 ± 94.6 0.002 
S Leptin (ng/ml) 52.8 ± 24.6 6.3 ± 3.1 0.001 
  
    Previously there was controversy about the 
relationship between leptin and insulin resistance.  
Some studies showed that serum leptin level was low 
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and insulin resistance was high while others disagree. 
Vidal et al. performed three-hour euglycemic 
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Fig 1:    Correlation between Serum leptin level 
and Body mass index (r=0.59, p=0.001) 
hyperinsulinemic clamp studies, in which they found 
that this clamp failed  to increase leptin  mRNA 
abundance in human adipose  tissue.16 Moreover, 
study subjects were healthy, not suffering from 
diabetes mellitus, cardiovascular disease, and 
depression but still had high insulin resistance, which 
seems to be purely related to obesity. In present study, 
indices of insulin secretion (HOMA-B) and insulin 
resistance (HOMA-IR) were evaluated from a fasting 
sample. Wallace et al., have suggested that insulin 
sensitivity and β-cell function are inextricably linked; 
they should be measured simultaneously because 
their interplay is fundamental to glucose tolerance. 6,17 
In the present study it was found that the subjects in 
obese group had hyperinsulinemia (FPI 15.1±7.1 
mIU/ml), and had decreased beta cell function 
(HOMA-B 61.6 ± 32.5 %) when compared with non 
obese group (FPI 3.4±1.7; HOMA-B 120 ± 94.6 %). It 
seems that a reciprocal relationship exists between 
insulin resistance and beta cell function. 
      Boden et. al showed hyperinsulinemia, during a 
period of 72 hours, increased serum leptin 
concentrations in a dose-dependent manner.18 
Cultured human and rat hepatoma cell lines studied 
by Cohen et al. have shown that leptin attenuates 
several insulin signals. 19 The hyperleptinemia found 
in obese group in this study and also in other studies, 
may be due to under-responsiveness to leptin. It 
means that obesity is associated with or even caused 
by a state of relative leptin resistance similar to the 
insulin resistance of type 2 diabetes.20,21  
 
Conclusion 
Leptin resistance and common form of obesity can be 
targeted by change in life style and diet. 
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